HAS3 and chronic obstructive pulmonary disease: While increased expression of HAS-3 may have been expected in patients with COPD, due to the low-grade systemic inflammation that is associated with the disease47 and known to increase its expression21, no differences in HAS-3 expression were observed between patients with COPD and (non)smoking controls in the present study.